SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004466
Filing Date
2021-11-15
Accepted
2021-11-15 07:42:18
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q freq-20210930.htm   iXBRL 10-Q 2797126
2 EX-31.1 freq-ex31_1.htm EX-31.1 17086
3 EX-31.2 freq-ex31_2.htm EX-31.2 17075
4 EX-32.1 freq-ex32_1.htm EX-32.1 10847
5 EX-32.2 freq-ex32_2.htm EX-32.2 10870
  Complete submission text file 0000950170-21-004466.txt   7957909

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT freq-20210930_cal.xml EX-101.CAL 37190
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT freq-20210930.xsd EX-101.SCH 40791
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT freq-20210930_pre.xml EX-101.PRE 284833
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT freq-20210930_def.xml EX-101.DEF 165073
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT freq-20210930_lab.xml EX-101.LAB 393947
11 EXTRACTED XBRL INSTANCE DOCUMENT freq-20210930_htm.xml XML 1197880
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 211406372
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences